Laine et al., identified that the E2F1-CIP2A positive feedback loop is a key determinant of breast cancer cell sensitivity to senescence and growth arrest induction [21] the results of which may also facilitate stratification strategies for selection of patients to receive senescence-inducing cancer therapies. This evidence concerns the gene CIP2A and breast carcinoma.